Editorially Independent content supported with advertising by Genentech
About This Editorial Feature
How are leading retina specialists leveraging anti-VEGF agents to treat patients with wet AMD and DME? Join experts as they review a variety of real-world cases from their clinics and use those cases as the starting point to discuss the latest innovations in anti-VEGF therapy.